查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
2019780

家庭静脉输液治疗市场规模、份额、成长及全球产业分析：按类型、应用和地区分類的洞察，2026-2034 年预测

Home Infusion Therapy Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 128 Pages | 商品交期: 请询问到货日

价格

家庭静脉输液治疗市场的成长要素

受消费者对经济高效、以患者为中心的医疗保健解决方案需求不断增长的推动，全球家庭输液治疗市场正经历显着增长。预计到2025年，该市场规模将达到424.4亿美元，2026年将成长至456.7亿美元，到2034年将达到1,289.1亿美元，预测期内复合年增长率高达13.85%。北美地区凭藉先进的医疗保健基础设施和有利的报销政策，引领市场发展，预计到2025年将占41.20%的市场份额。

居家输液治疗是指在患者家中进行生物製药及静脉注射药物等治疗。这种方法可以减少患者就医次数，降低治疗费用，并提高患者的舒适度。人们对居家医疗的日益重视，以及输液治疗设备的科技进步，正在加速居家输液治疗在全球的普及。

市场趋势

塑造市场格局的关键趋势之一是向居家医疗的转变。由于便利性、缩短住院时间以及降低院内感染风险等原因，患者和医疗服务提供者越来越倾向于居家治疗。远端医疗、穿戴式监测设备和携带式输液系统的整合进一步提高了居家输液治疗的安全性和有效性。

此外，新冠肺炎疫情加剧了这一转变，加重了医院的负担，并促使患者寻求更安全的替代方案。自从疫情爆发以来，这一趋势仍在继续，分散式医疗模式在医疗保健系统中变得越来越重要。

市场成长要素

成长要素之一是癌症、糖尿病和免疫系统疾病等慢性病盛行率的上升。这些疾病通常需要长期输液治疗，因此居家治疗方案更具吸引力。此外，老年人口的成长也进一步促进了市场成长，老年人更倾向于居家治疗。

另一个重要因素是人们对经济实惠的医疗保健需求日益增长。居家静脉输液治疗可显着降低住院费用及相关支出。研究表明，居家静脉输液治疗比住院治疗便宜得多，这促使患者和医疗服务提供者更广泛地采用这种治疗方式。

此外，人们对医院感染的担忧日益加剧，导致人们开始转向居家治疗方案，特别是对于免疫系统较弱的患者而言。

市场限制因素

儘管市场成长强劲，但仍面临诸多挑战。发展中地区缺乏报销机制仍是一大障碍。高昂的自付医疗费用和有限的保险覆盖范围限制了患者获得居家输液服务的机会。

此外，新兴市场缺乏熟练的医疗保健专业人员和基础设施不发达，也会阻碍家庭静脉输液疗法的广泛应用。

市场区隔分析

从产品类型来看，市场区隔将市场分为药品、医疗设备和服务三大类。预计到2026年，药品领域将占据市场主导地位，市场份额达到77.54%，这主要得益于注射药物核准的增加以及生物製药产品线的强劲增长。

根据适应症，市场可细分为抗感染疾病疗法、化疗、经肠营养和其他领域。由于抗感染疾病应用广泛且成本效益高，预计到2026年，该领域将以25.52%的市场份额占据主导地位。同时，由于癌症发生率不断上升，化疗领域预计将经历最快的增长。

区域趋势

北美仍然是一个关键地区，预计到 2025 年市场规模将达到 174.9 亿美元，到 2026 年将扩大到 186.9 亿美元。该地区受益于强大的居家医疗提供者网路和支持性的报销制度。

预计到 2025 年，欧洲的市场规模将达到 136.9 亿美元，由于各国政府加强推广居家医疗，预计市场将保持稳定成长。

预计到 2025 年，亚太地区的市场规模将达到 80.7 亿美元，成长速度最快，这主要得益于中国和印度等国家医疗保健意识的提高、慢性病负担的加重以及医疗保健基础设施的扩张。

目录

第一章：引言

第二章执行摘要

第三章 市场动态

  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场趋势

第四章：主要考虑因素

  • 2025年主要国家和地区主要慢性病盛行率
  • 新产品发布：按主要企业划分
  • 併购、收购和合作等主要产业趋势
  • 各国/地区的法规和还款状况
  • 新冠疫情对市场的影响

第五章：2021-2034年全球家庭静脉输液治疗市场分析、洞察与预测

  • 市场分析、洞察与预测：按产品划分。
    • 装置
    • 製药
    • 服务
  • 市场分析、洞察与预测：按指标
    • 感染疾病物
    • 化疗
    • 水疗法
    • 经肠营养
    • 全静脉营养
    • 免疫球蛋白疗法
    • 其他的
  • 市场分析、洞察与预测：按地区划分
    • 北美洲
    • 欧洲
    • 亚太地区
    • 世界其他地区

第六章：北美家庭静脉输液治疗市场分析、洞察与预测（2021-2034年）

  • 国家
    • 我们
    • 加拿大

第七章：欧洲家庭静脉输液治疗市场分析、洞察与预测（2021-2034年）

  • 国家
    • 英国
    • 德国
    • 法国
    • 西班牙
    • 义大利
    • 斯堪地那维亚
    • 其他欧洲国家

第八章：亚太地区家庭输液治疗市场分析、洞察与预测（2021-2034年）

  • 国家
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 其他亚太国家

第九章：全球其他地区家庭输液治疗市场分析、洞察与预测（2021-2034年）

第十章 竞争分析

  • 全球市占率分析（2025 年）
  • 公司简介
    • Option Care Health Inc.Overview
    • Optum, Inc.
    • CareCentrix, Inc.
    • Lincare Holdings Inc.
    • BriovaRx Infusion Services
    • Promptcare
    • Baxter
    • B. Braun Melsungen AG
    • Infusystem
    • Moog Inc.
Product Code: FBI102989

Growth Factors of home infusion therapy Market

The global home infusion therapy market is witnessing significant expansion, driven by the rising demand for cost-effective and patient-centric healthcare solutions. The market was valued at USD 42.44 billion in 2025 and is projected to grow to USD 45.67 billion in 2026, reaching USD 128.91 billion by 2034, exhibiting a strong CAGR of 13.85% during the forecast period. North America dominated the market with a 41.20% share in 2025, supported by advanced healthcare infrastructure and favorable reimbursement policies.

Home infusion therapy refers to the administration of medications such as biologics and intravenous drugs in a patient's home setting. This approach reduces hospital visits, lowers treatment costs, and enhances patient comfort. Increasing awareness of home-based healthcare, along with technological advancements in infusion devices, is accelerating global adoption.

Market Trends

A major trend shaping the market is the shift toward home-based medical care. Patients and healthcare providers are increasingly preferring home treatment due to convenience, reduced hospital stays, and lower risk of hospital-acquired infections. The integration of telehealth, wearable monitoring devices, and portable infusion systems has further improved the safety and efficiency of home infusion therapies.

Additionally, the COVID-19 pandemic accelerated this transition, as hospitals were overburdened and patients sought safer alternatives. The trend continues post-pandemic, with healthcare systems emphasizing decentralized care models.

Market Growth Drivers

One of the primary growth drivers is the rising prevalence of chronic diseases such as cancer, diabetes, and immune disorders. These conditions often require long-term infusion therapies, making home-based solutions highly attractive. The increasing geriatric population, which prefers receiving treatment at home, further supports market growth.

Another key factor is the growing demand for cost-effective healthcare. Home infusion therapy significantly reduces hospitalization expenses and associated costs. Studies indicate that home-based infusion treatments can be substantially cheaper than hospital-based care, encouraging wider adoption among patients and healthcare providers.

Moreover, increasing concerns about hospital-acquired infections are pushing patients toward home treatment options, especially those with compromised immune systems.

Market Restraints

Despite strong growth, the market faces certain challenges. The lack of reimbursement policies in developing regions remains a major barrier. High out-of-pocket healthcare expenses and limited insurance coverage restrict patient access to home infusion services.

Additionally, shortage of skilled healthcare professionals and limited infrastructure in emerging markets can hinder the widespread adoption of home infusion therapy.

Market Segmentation Analysis

By product type, the market is segmented into drugs, devices, and services. The drugs segment dominated the market with a 77.54% share in 2026, driven by increasing approvals of injectable therapies and a strong pipeline of biologics.

By indication, the market includes anti-infective therapies, chemotherapy, enteral nutrition, and others. The anti-infective segment led the market with a 25.52% share in 2026, owing to its widespread use and cost-effectiveness. Meanwhile, the chemotherapy segment is expected to witness the fastest growth due to rising cancer prevalence.

Regional Insights

North America remains the leading region, with a market size of USD 17.49 billion in 2025, growing to USD 18.69 billion in 2026. The region benefits from a strong network of home healthcare providers and supportive reimbursement frameworks.

Europe accounted for USD 13.69 billion in 2025 and is expected to grow steadily due to increasing government initiatives promoting home healthcare.

Asia Pacific, valued at USD 8.07 billion in 2025, is projected to witness the fastest growth due to rising healthcare awareness, increasing chronic disease burden, and expanding healthcare infrastructure in countries such as China and India.

Competitive Landscape

The market is moderately consolidated, with key players such as Option Care Health, Optum, CVS Health, and Baxter International focusing on expanding service offerings and technological innovations. Strategic collaborations, acquisitions, and partnerships are commonly adopted to strengthen market presence and improve patient access to home infusion services.

Conclusion

The home infusion therapy market is poised for robust growth, driven by the increasing need for cost-effective, patient-friendly healthcare solutions. With market value expected to rise from USD 42.44 billion in 2025 to USD 128.91 billion by 2034, the industry reflects strong long-term potential. While challenges such as reimbursement limitations and infrastructure gaps persist, advancements in technology, supportive government initiatives, and growing patient preference for home-based care will continue to drive market expansion.

Segmentation By Product

  • Devices
  • Drugs
  • Services

By Indication

  • Anti-Infective
  • Chemotherapy
  • Hydration Therapy
  • Enteral Nutrition
  • Total Parenteral Nutrition
  • Immunoglobulin Therapy
  • Others

By Geography

  • North America (By Product, By Indication, and By Country)
    • U.S. (By Indication)
    • Canada (By Indication)
  • Europe (By Product, By Indication, and By Country/Sub-region)
    • U.K. (By Indication)
    • Germany (By Indication)
    • France (By Indication)
    • Italy (By Indication)
    • Spain (By Indication)
    • Scandinavia (By Indication)
    • Rest of Europe (By Indication)
  • Asia Pacific (By Product, By Indication, and By Country/Sub-region)
    • Japan (By Indication)
    • India (By Indication)
    • China (By Indication)
    • Australia (By Indication)
    • Rest of Asia Pacific (By Indication)
  • Rest of the World (By Product and By Indication)

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Prevalence of Key Chronic Diseases, Key Countries/Regions, 2025
  • 4.2. New Product Launches, By Key Players
  • 4.3. Key Industry Development such as Mergers, Acquisition, and Partnerships
  • 4.4. Regulatory & Reimbursements Scenario, By Countries/Regions
  • 4.5. Covid-19 Impact on the Market

5. Global Home Infusion Therapy Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Product
    • 5.1.1. Devices
    • 5.1.2. Drugs
    • 5.1.3. Services
  • 5.2. Market Analysis, Insights and Forecast - By Indication
    • 5.2.1. Anti-Infective
    • 5.2.2. Chemotherapy
    • 5.2.3. Hydration Therapy
    • 5.2.4. Enternal Nutrition
    • 5.2.5. Total Parenteral Nutrition
    • 5.2.6. Immunoglobulin Therapy
    • 5.2.7. Others
  • 5.3. Market Analysis, Insights and Forecast - By Region
    • 5.3.1. North America
    • 5.3.2. Europe
    • 5.3.3. Asia Pacific
    • 5.3.4. Rest of the World

6. North America Home Infusion Therapy Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Product
    • 6.1.1. Devices
    • 6.1.2. Drugs
    • 6.1.3. Services
  • 6.2. Market Analysis, Insights and Forecast - By Indication
    • 6.2.1. Anti-Infective
    • 6.2.2. Chemotherapy
    • 6.2.3. Hydration Therapy
    • 6.2.4. Enternal Nutrition
    • 6.2.5. Total Parenteral Nutrition
    • 6.2.6. Immunoglobulin Therapy
    • 6.2.7. Others
  • 6.3. Market Analysis, Insights and Forecast - By Country
    • 6.3.1. U.S.
      • 6.3.1.1. By Indication
    • 6.3.2. Canada
      • 6.3.2.1. By Indication

7. Europe Home Infusion Therapy Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Product
    • 7.1.1. Devices
    • 7.1.2. Drugs
    • 7.1.3. Services
  • 7.2. Market Analysis, Insights and Forecast - By Indication
    • 7.2.1. Anti-Infective
    • 7.2.2. Chemotherapy
    • 7.2.3. Hydration Therapy
    • 7.2.4. Enternal Nutrition
    • 7.2.5. Total Parenteral Nutrition
    • 7.2.6. Immunoglobulin Therapy
    • 7.2.7. Others
  • 7.3. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 7.3.1. U.K.
      • 7.3.1.1. By Indication
    • 7.3.2. Germany
      • 7.3.2.1. By Indication
    • 7.3.3. France
      • 7.3.3.1. By Indication
    • 7.3.4. Spain
      • 7.3.4.1. By Indication
    • 7.3.5. Italy
      • 7.3.5.1. By Indication
    • 7.3.6. Scandinavia
      • 7.3.6.1. By Indication
    • 7.3.7. Rest of Europe
      • 7.3.7.1. By Indication

8. Asia Pacific Home Infusion Therapy Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Product
    • 8.1.1. Devices
    • 8.1.2. Drugs
    • 8.1.3. Services
  • 8.2. Market Analysis, Insights and Forecast - By Indication
    • 8.2.1. Anti-Infective
    • 8.2.2. Chemotherapy
    • 8.2.3. Hydration Therapy
    • 8.2.4. Enternal Nutrition
    • 8.2.5. Total Parenteral Nutrition
    • 8.2.6. Immunoglobulin Therapy
    • 8.2.7. Others
  • 8.3. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 8.3.1. Japan
      • 8.3.1.1. By Indication
    • 8.3.2. China
      • 8.3.2.1. By Indication
    • 8.3.3. India
      • 8.3.3.1. By Indication
    • 8.3.4. Australia
      • 8.3.4.1. By Indication
    • 8.3.5. Rest of Asia Pacific
      • 8.3.5.1. By Indication

9. Rest of the World Home Infusion Therapy Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Product
    • 9.1.1. Devices
    • 9.1.2. Drugs
    • 9.1.3. Services
  • 9.2. Market Analysis, Insights and Forecast - By Indication
    • 9.2.1. Anti-Infective
    • 9.2.2. Chemotherapy
    • 9.2.3. Hydration Therapy
    • 9.2.4. Enternal Nutrition
    • 9.2.5. Total Parenteral Nutrition
    • 9.2.6. Immunoglobulin Therapy
    • 9.2.7. Others

10. Competitive Analysis

  • 10.1. Global Market Share Analysis (2025)
  • 10.2. Company Profiles
    • 10.2.1. Option Care Health Inc.Overview
      • 10.2.1.1. Products & Services
      • 10.2.1.2. SWOT Analysis
      • 10.2.1.3. Recent Developments
      • 10.2.1.4. Strategies
      • 10.2.1.5. Financials (Based on Availability)
    • 10.2.2. Optum, Inc.
      • 10.2.2.1. Products & Services
      • 10.2.2.2. SWOT Analysis
      • 10.2.2.3. Recent Developments
      • 10.2.2.4. Strategies
      • 10.2.2.5. Financials (Based on Availability)
    • 10.2.3. CareCentrix, Inc.
      • 10.2.3.1. Products & Services
      • 10.2.3.2. SWOT Analysis
      • 10.2.3.3. Recent Developments
      • 10.2.3.4. Strategies
      • 10.2.3.5. Financials (Based on Availability)
    • 10.2.4. Lincare Holdings Inc.
      • 10.2.4.1. Products & Services
      • 10.2.4.2. SWOT Analysis
      • 10.2.4.3. Recent Developments
      • 10.2.4.4. Strategies
      • 10.2.4.5. Financials (Based on Availability)
    • 10.2.5. BriovaRx Infusion Services
      • 10.2.5.1. Products & Services
      • 10.2.5.2. SWOT Analysis
      • 10.2.5.3. Recent Developments
      • 10.2.5.4. Strategies
      • 10.2.5.5. Financials (Based on Availability)
    • 10.2.6. Promptcare
      • 10.2.6.1. Products & Services
      • 10.2.6.2. SWOT Analysis
      • 10.2.6.3. Recent Developments
      • 10.2.6.4. Strategies
      • 10.2.6.5. Financials (Based on Availability)
    • 10.2.7. Baxter
      • 10.2.7.1. Products & Services
      • 10.2.7.2. SWOT Analysis
      • 10.2.7.3. Recent Developments
      • 10.2.7.4. Strategies
      • 10.2.7.5. Financials (Based on Availability)
    • 10.2.8. B. Braun Melsungen AG
      • 10.2.8.1. Products & Services
      • 10.2.8.2. SWOT Analysis
      • 10.2.8.3. Recent Developments
      • 10.2.8.4. Strategies
      • 10.2.8.5. Financials (Based on Availability)
    • 10.2.9. Infusystem
      • 10.2.9.1. Products & Services
      • 10.2.9.2. SWOT Analysis
      • 10.2.9.3. Recent Developments
      • 10.2.9.4. Strategies
      • 10.2.9.5. Financials (Based on Availability)
    • 10.2.10. Moog Inc.
      • 10.2.10.1. Products & Services
      • 10.2.10.2. SWOT Analysis
      • 10.2.10.3. Recent Developments
      • 10.2.10.4. Strategies
      • 10.2.10.5. Financials (Based on Availability)

List of Tables

  • Table 1: Global Home Infusion Therapy Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 2: Global Home Infusion Therapy Market Revenue (USD billion) Forecast, by Indication, 2021-2034
  • Table 3: Global Home Infusion Therapy Market Revenue (USD billion) Forecast, by Region, 2021-2034
  • Table 4: North America Home Infusion Therapy Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 5: North America Home Infusion Therapy Market Revenue (USD billion) Forecast, by Indication, 2021-2034
  • Table 6: North America Home Infusion Therapy Market Revenue (USD billion) Forecast, By Country, 2021-2034
  • Table 7: Europe Home Infusion Therapy Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 8: Europe Home Infusion Therapy Market Revenue (USD billion) Forecast, by Indication, 2021-2034
  • Table 9: Europe Home Infusion Therapy Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 10: Asia Pacific Home Infusion Therapy Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 11: Asia Pacific Home Infusion Therapy Market Revenue (USD billion) Forecast, by Indication, 2021-2034
  • Table 12: Asia Pacific Home Infusion Therapy Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 13: Rest of the World Home Infusion Therapy Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 14: Rest of the World Home Infusion Therapy Market Revenue (USD billion) Forecast, by Indication, 2021-2034

List of Figures

  • Figure 1: Global Home Infusion Therapy Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034
  • Figure 2: Global Home Infusion Therapy Market Value Share (%), by Product, 2025 & 2034
  • Figure 3: Global Home Infusion Therapy Market Value Share (%), by Indication, 2025 & 2034
  • Figure 4: Global Home Infusion Therapy Market Value (USD billion), by Region, 2025 & 2034
  • Figure 5: North America Home Infusion Therapy Market Value (USD billion), by Product, 2025 & 2034
  • Figure 6: North America Home Infusion Therapy Market Value Share (%), by Product, 2025
  • Figure 7: North America Home Infusion Therapy Market Value (USD billion), by Indication, 2025 & 2034
  • Figure 8: North America Home Infusion Therapy Market Value Share (%), by Indication, 2025
  • Figure 9: North America Home Infusion Therapy Market Value (USD billion), By Country, 2025 & 2034
  • Figure 10: North America Home Infusion Therapy Market Value Share (%), By Country, 2025
  • Figure 11: Europe Home Infusion Therapy Market Value (USD billion), by Product, 2025 & 2034
  • Figure 12: Europe Home Infusion Therapy Market Value Share (%), by Product, 2025
  • Figure 13: Europe Home Infusion Therapy Market Value (USD billion), by Indication, 2025 & 2034
  • Figure 14: Europe Home Infusion Therapy Market Value Share (%), by Indication, 2025
  • Figure 15: Europe Home Infusion Therapy Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 16: Europe Home Infusion Therapy Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 17: Asia Pacific Home Infusion Therapy Market Value (USD billion), by Product, 2025 & 2034
  • Figure 18: Asia Pacific Home Infusion Therapy Market Value Share (%), by Product, 2025
  • Figure 19: Asia Pacific Home Infusion Therapy Market Value (USD billion), by Indication, 2025 & 2034
  • Figure 20: Asia Pacific Home Infusion Therapy Market Value Share (%), by Indication, 2025
  • Figure 21: Asia Pacific Home Infusion Therapy Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 22: Asia Pacific Home Infusion Therapy Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 23: Rest of the World Home Infusion Therapy Market Value (USD billion), by Product, 2025 & 2034
  • Figure 24: Rest of the World Home Infusion Therapy Market Value Share (%), by Product, 2025
  • Figure 25: Rest of the World Home Infusion Therapy Market Value (USD billion), by Indication, 2025 & 2034
  • Figure 26: Rest of the World Home Infusion Therapy Market Value Share (%), by Indication, 2025
  • Figure 27: Global Home Infusion Therapy Market Share (%), By Company, 2025